Cargando…

Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians

Background:  The diagnosis of Alzheimer's disease (AD) can bring financial and emotional consequences to patients and caregivers. Whether or not the diagnosis should be disclosed to patients is a matter of debate amongst physicians and can be influenced by culture and experience. Objective:  To...

Descripción completa

Detalles Bibliográficos
Autores principales: Souza, Vitor Santos de, Guazzelli, Sofia Brunchport, Cruz, Leonardo Cardoso, Resende, Elisa de Paula França, Souza, Leonardo Cruz de, Barbosa, Maira Tonidandel, Caramelli, Paulo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Revinter Publicações Ltda. 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631852/
https://www.ncbi.nlm.nih.gov/pubmed/37939720
http://dx.doi.org/10.1055/s-0043-1776316
_version_ 1785146102472769536
author Souza, Vitor Santos de
Guazzelli, Sofia Brunchport
Cruz, Leonardo Cardoso
Resende, Elisa de Paula França
Souza, Leonardo Cruz de
Barbosa, Maira Tonidandel
Caramelli, Paulo
author_facet Souza, Vitor Santos de
Guazzelli, Sofia Brunchport
Cruz, Leonardo Cardoso
Resende, Elisa de Paula França
Souza, Leonardo Cruz de
Barbosa, Maira Tonidandel
Caramelli, Paulo
author_sort Souza, Vitor Santos de
collection PubMed
description Background:  The diagnosis of Alzheimer's disease (AD) can bring financial and emotional consequences to patients and caregivers. Whether or not the diagnosis should be disclosed to patients is a matter of debate amongst physicians and can be influenced by culture and experience. Objective:  To investigate the current practice of physicians who attend and treat patients with dementia in Brazil regarding the disclosure of dementia diagnosis and compare the practice with what has been performed 15 years ago in the country. Methods:  Data were evaluated using an electronic questionnaire. The questions used to carry out this research were similar to the questions of the study carried out 15 years ago 9. The form was sent to the Brazilian Academy of Neurology, the Brazilian Association of Geriatrics and Gerontology, and the Brazilian Association of Psychiatry, which forwarded it to their members. Analyses were conducted through non-parametric statistical tests, with a post-hoc assessment. Results:  397 physicians responded to the survey, of which 231 are neurologists, 124 geriatricians, 29 psychiatrists and 13 from other specialties. The mean age was 45.2 years. The majority (66.7%) of the physicians reveal the diagnosis of AD always or usually. The youngest group of neurologists were more likely to disclose the diagnosis than the oldest group with a significant difference between them. In comparison to the 2008 Brazilian study, the percentage of physicians who always or usually disclose the diagnosis has risen by 22%. On the other hand, 12.3% of the physicians rarely or never disclose the diagnosis, in comparison to 25,3% in 2008. The main reasons for not disclosing the diagnosis concern the patients' mental health. Conclusion:  Advances in dementia knowledge and biomarkers availability probably explain the increase in the rate of disclosure. The main challenge is to reconcile the autonomy of affected individuals, mental health issues after the diagnosis and the family member's opinion.
format Online
Article
Text
id pubmed-10631852
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Thieme Revinter Publicações Ltda.
record_format MEDLINE/PubMed
spelling pubmed-106318522023-11-15 Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians Souza, Vitor Santos de Guazzelli, Sofia Brunchport Cruz, Leonardo Cardoso Resende, Elisa de Paula França Souza, Leonardo Cruz de Barbosa, Maira Tonidandel Caramelli, Paulo Arq Neuropsiquiatr Background:  The diagnosis of Alzheimer's disease (AD) can bring financial and emotional consequences to patients and caregivers. Whether or not the diagnosis should be disclosed to patients is a matter of debate amongst physicians and can be influenced by culture and experience. Objective:  To investigate the current practice of physicians who attend and treat patients with dementia in Brazil regarding the disclosure of dementia diagnosis and compare the practice with what has been performed 15 years ago in the country. Methods:  Data were evaluated using an electronic questionnaire. The questions used to carry out this research were similar to the questions of the study carried out 15 years ago 9. The form was sent to the Brazilian Academy of Neurology, the Brazilian Association of Geriatrics and Gerontology, and the Brazilian Association of Psychiatry, which forwarded it to their members. Analyses were conducted through non-parametric statistical tests, with a post-hoc assessment. Results:  397 physicians responded to the survey, of which 231 are neurologists, 124 geriatricians, 29 psychiatrists and 13 from other specialties. The mean age was 45.2 years. The majority (66.7%) of the physicians reveal the diagnosis of AD always or usually. The youngest group of neurologists were more likely to disclose the diagnosis than the oldest group with a significant difference between them. In comparison to the 2008 Brazilian study, the percentage of physicians who always or usually disclose the diagnosis has risen by 22%. On the other hand, 12.3% of the physicians rarely or never disclose the diagnosis, in comparison to 25,3% in 2008. The main reasons for not disclosing the diagnosis concern the patients' mental health. Conclusion:  Advances in dementia knowledge and biomarkers availability probably explain the increase in the rate of disclosure. The main challenge is to reconcile the autonomy of affected individuals, mental health issues after the diagnosis and the family member's opinion. Thieme Revinter Publicações Ltda. 2023-11-08 /pmc/articles/PMC10631852/ /pubmed/37939720 http://dx.doi.org/10.1055/s-0043-1776316 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Souza, Vitor Santos de
Guazzelli, Sofia Brunchport
Cruz, Leonardo Cardoso
Resende, Elisa de Paula França
Souza, Leonardo Cruz de
Barbosa, Maira Tonidandel
Caramelli, Paulo
Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians
title Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians
title_full Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians
title_fullStr Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians
title_full_unstemmed Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians
title_short Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians
title_sort diagnostic disclosure of alzheimer's disease in brazil: a national survey of specialized physicians
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631852/
https://www.ncbi.nlm.nih.gov/pubmed/37939720
http://dx.doi.org/10.1055/s-0043-1776316
work_keys_str_mv AT souzavitorsantosde diagnosticdisclosureofalzheimersdiseaseinbrazilanationalsurveyofspecializedphysicians
AT guazzellisofiabrunchport diagnosticdisclosureofalzheimersdiseaseinbrazilanationalsurveyofspecializedphysicians
AT cruzleonardocardoso diagnosticdisclosureofalzheimersdiseaseinbrazilanationalsurveyofspecializedphysicians
AT resendeelisadepaulafranca diagnosticdisclosureofalzheimersdiseaseinbrazilanationalsurveyofspecializedphysicians
AT souzaleonardocruzde diagnosticdisclosureofalzheimersdiseaseinbrazilanationalsurveyofspecializedphysicians
AT barbosamairatonidandel diagnosticdisclosureofalzheimersdiseaseinbrazilanationalsurveyofspecializedphysicians
AT caramellipaulo diagnosticdisclosureofalzheimersdiseaseinbrazilanationalsurveyofspecializedphysicians